TRIMTECH Therapeutics
PrivateLast Round
Seed
Jun 23, 2026
Total Funding Raised
$61M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TRIMTECH Therapeutics is a biotechnology company that is developing a targeted protein degradation platform designed to address neurodegenerative diseases by degrading toxic protein aggregates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRIMTECH Therapeutics Comparables
Compare TRIMTECH Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plexium | 79% | |
| Amphista Therapeutics | 79% | |
| SEED Therapeutics | 76% | |
TRIMTECH Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 23, 2026 | ||||
| Seed | Mar 5, 2025 |
Key People
Founding team and executive leadership
TRIMTECH Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MP Healthcare Venture Management | Seed |
| Start Codon | Seed |
| Cambridge Enterprise Ventures | Seed |
| BGF | Seed |
| M Ventures | Seed |
| Cambridge Innovation Capital | Seed |
| Johnson & Johnson Innovation - JJDC, Inc. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
$14M round led by Johnson & Johnson Innovation - JJDC, Inc. and BGF.
- May 18, 2026
Monthly visitors increased 814% MoM, reaching 631.
TRIMTECH Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TRIMTECH Therapeutics's valuation, stock price, and market status.